AUGMENT-101
Syndax Pharmaceuticals
Syndax Pharmaceuticals
AvenCell Therapeutics, Inc.
Dren Bio
Allogene Therapeutics
University of Chicago
Ossium Health, Inc.
City of Hope Medical Center
Seattle Children's Hospital
Vironexis Biotherapeutics Inc.
Dana-Farber Cancer Institute
Incyte Corporation
Memorial Sloan Kettering Cancer Center
AstraZeneca
Sheba Medical Center
Incyte Corporation
Dana-Farber Cancer Institute
Memorial Sloan Kettering Cancer Center
Kura Oncology, Inc.
AVM Biotechnology Inc
UNC Lineberger Comprehensive Cancer Center
CRISPR Therapeutics
Incyte Corporation
National Institutes of Health Clinical Center (CC)
Biotroy Therapeutics
Princess Maxima Center for Pediatric Oncology
Princess Maxima Center for Pediatric Oncology
Princess Maxima Center for Pediatric Oncology
Princess Maxima Center for Pediatric Oncology
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Seattle Children's Hospital
CRISPR Therapeutics
Princess Maxima Center for Pediatric Oncology
M.D. Anderson Cancer Center
Thomas Jefferson University
Thomas Jefferson University
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Children's Hospital of Philadelphia
City of Hope Medical Center
Takara Bio Inc.
Assiut University
Celgene
Princess Maxima Center for Pediatric Oncology
Kyowa Kirin Co., Ltd.
AO GENERIUM
National Institutes of Health Clinical Center (CC)
Bellicum Pharmaceuticals
University of Nebraska
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
Chongqing Precision Biotech Co., Ltd